AI-enhanced RNA delivery platform using evolution-inspired approaches to advance siRNA and mRNA therapeutics.
Sixfold Bio is developing a patented drug delivery system for RNA therapies, including siRNAs for gene silencing and mRNAs for gene expression. The company combines evolutionary biology approaches with AI to optimize delivery solutions, targeting commercialization of its RNA delivery platform for pharmaceutical partners. The company's Mergo platform is its featured delivery technology. Sixfold Bio is a product of Sixfold Bioscience.